A Phase II Trial Evaluating Weekly Docetaxel and Capecitabine in Patients with Metastatic or Advanced, Locally Recurrent Head and Neck Cancers

By Zhang Jingsong   Lee Julia   Urba Susan   Foster Jared   Worden Francis  

Cancer Investigation, Vol. 28, Iss. 9, 2010-10 ,pp. : 910-916

Informa Healthcare

Access to resources Recommend Favorite

Weekly Carboplatin and Docetaxel for Locally Advanced Primary and Recurrent Cervical Cancer: A Phase I Study

By Rein D.T.   Kurbacher C.M.   Breidenbach M.   Schöndorf T.   Schmidt T.   König E.       Mallmann P.  

Gynecologic Oncology, Vol. 87, Iss. 1, 2002-10 ,pp. : 98-103

Academic Press

Access to resources Recommend Favorite

Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients

By Smith John   Vukelja Svetislava   Rabe Amy   Wentworth-Hartung Nicole   Koutrelakos Nicholas   Shao Spencer   Whittaker Thomas   Wang Yunfei   Asmar Lina   McDowell Diane   Mukhopadhyay Pralay   O’Shaughnessy Joyce  

Breast Cancer Research and Treatment, Vol. 142, Iss. 2, 2013-11 ,pp. : 381-388

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer

By Song Hong   Do Young   Chang Heung   Ryu Min   Lee Kyung   Kim Yeul   Hong Dae   Cho Jae   Lee Kyoung   Kim Si  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 763-768

Springer Publishing Company

Access to resources Recommend Favorite